Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Alexander MM Eggermont,Stefan Suciu,Mario Santinami,Alessandro Testori,Wim HJ Kruit,Jeremy Marsden,Cornelis JA Punt,François Salès,Martin Gore,Rona MacKie,Zvonko Kusic,Reinhard Dummer,Axel Hauschild,Elena Musat,Alain Spatz,Ulrich Keilholz
12–18 July 2008
Copyright © 2008, Elsevier
Welcome to RightsLink
Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.
I would like to...
To request permission for a type of use not listed, please contact Elsevier Global Rights Department.Are you the author of this Elsevier journal article?
Clearance Center, Inc. All Rights Reserved.
Comments? We would like to hear from you. E-mail us at